BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 10466570)

  • 1. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
    Gorga MP; Neely ST; Dorn PA
    Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation and potential clinical application of multivariate analyses of distortion-product otoacoustic emission data.
    Gorga MP; Dierking DM; Johnson TA; Beauchaine KL; Garner CA; Neely ST
    Ear Hear; 2005 Dec; 26(6):593-607. PubMed ID: 16377995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of neonatal hearing impairment: evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance.
    Norton SJ; Gorga MP; Widen JE; Folsom RC; Sininger Y; Cone-Wesson B; Vohr BR; Mascher K; Fletcher K
    Ear Hear; 2000 Oct; 21(5):508-28. PubMed ID: 11059707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss.
    Gorga MP; Neely ST; Ohlrich B; Hoover B; Redner J; Peters J
    Ear Hear; 1997 Dec; 18(6):440-55. PubMed ID: 9416447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.
    Johnson TA; Neely ST; Kopun JG; Dierking DM; Tan H; Gorga MP
    Ear Hear; 2010 Feb; 31(1):74-83. PubMed ID: 19701088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of aging on distortion-product otoacoustic emissions in adults with normal hearing.
    Uchida Y; Ando F; Shimokata H; Sugiura S; Ueda H; Nakashima T
    Ear Hear; 2008 Apr; 29(2):176-84. PubMed ID: 18595184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting audiometric status from distortion product otoacoustic emissions using multivariate analyses.
    Dorn PA; Piskorski P; Gorga MP; Neely ST; Keefe DH
    Ear Hear; 1999 Apr; 20(2):149-63. PubMed ID: 10229516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neonatal hearing impairment: distortion product otoacoustic emissions during the perinatal period.
    Gorga MP; Norton SJ; Sininger YS; Cone-Wesson B; Folsom RC; Vohr BR; Widen JE; Neely ST
    Ear Hear; 2000 Oct; 21(5):400-24. PubMed ID: 11059701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distortion product otoacoustic emissions for the assessment of auditory sensitivity].
    Chida E
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Nov; 101(11):1335-47. PubMed ID: 9867000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Clinical Interpretation of Distortion Product Otoacoustic Emissions in Infants.
    Blankenship CM; Hunter LL; Keefe DH; Feeney MP; Brown DK; McCune A; Fitzpatrick DF; Lin L
    Ear Hear; 2018; 39(6):1075-1090. PubMed ID: 29517520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient evoked otoacoustic emissions in patients with normal hearing and in patients with hearing loss.
    Hussain DM; Gorga MP; Neely ST; Keefe DH; Peters J
    Ear Hear; 1998 Dec; 19(6):434-49. PubMed ID: 9867292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
    Nieschalk M; Hustert B; Stoll W
    Audiology; 1998; 37(2):83-99. PubMed ID: 9547922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.